Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy.

Journal of clinical medicine(2023)

引用 1|浏览10
暂无评分
摘要
The present study suggests a potential positive role of anti-GB3 antibodies as a marker of overlapping cardiac inflammation in patients with FDCM.
更多
查看译文
关键词
fabry disease cardiomyopathy,myocardial inflammation,biomarker,antibody
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要